These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

666 related items for PubMed ID: 15493040

  • 21. Inhibitor antibody development and T cell response to human factor VIII in murine hemophilia A.
    Qian J, Borovok M, Bi L, Kazazian HH, Hoyer LW.
    Thromb Haemost; 1999 Feb; 81(2):240-4. PubMed ID: 10063999
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. [Generation of factor VIII gene knockout mouse by tetraploid embryo complementation technology].
    Kuang Y, Wang J, Lu X, Lu S, Zhang L, Shen C, Fei J, Wang Z.
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2010 Feb; 27(1):1-6. PubMed ID: 20140858
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Strain related variations in adenovirally mediated transgene expression from mouse hepatocytes in vivo: comparisons between immunocompetent and immunodeficient inbred strains.
    Barr D, Tubb J, Ferguson D, Scaria A, Lieber A, Wilson C, Perkins J, Kay MA.
    Gene Ther; 1995 Mar; 2(2):151-5. PubMed ID: 7719932
    [Abstract] [Full Text] [Related]

  • 28. Theodore E. Woodward Award. AAV-mediated gene transfer for hemophilia.
    High KA.
    Trans Am Clin Climatol Assoc; 2003 Mar; 114():337-51; discussion 351-2. PubMed ID: 12813929
    [Abstract] [Full Text] [Related]

  • 29. Long-term persistence of anti-factor VIII antibody-secreting cells in hemophilic mice after treatment with human factor VIII.
    Hausl C, Maier E, Schwarz HP, Ahmad RU, Turecek PL, Dorner F, Reipert BM.
    Thromb Haemost; 2002 May; 87(5):840-5. PubMed ID: 12038787
    [Abstract] [Full Text] [Related]

  • 30. FVIII gene delivery by muscle electroporation corrects murine hemophilia A.
    Long YC, Jaichandran S, Ho LP, Tien SL, Tan SY, Kon OL.
    J Gene Med; 2005 Apr; 7(4):494-505. PubMed ID: 15521095
    [Abstract] [Full Text] [Related]

  • 31. Promoters influence the kinetics of transgene expression following adenovector gene delivery.
    Chen P, Tian J, Kovesdi I, Bruder JT.
    J Gene Med; 2008 Feb; 10(2):123-31. PubMed ID: 18064718
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Role of CD154 in the secondary immune response: the reduction of pre-existing splenic germinal centers and anti-factor VIII inhibitor titer.
    Qian J, Burkly LC, Smith EP, Ferrant JL, Hoyer LW, Scott DW, Haudenschild CC.
    Eur J Immunol; 2000 Sep; 30(9):2548-54. PubMed ID: 11009088
    [Abstract] [Full Text] [Related]

  • 37. Sustained expression of human apo A-I following adenoviral gene transfer in mice.
    De Geest B, Van Linthout S, Collen D.
    Gene Ther; 2001 Jan; 8(2):121-7. PubMed ID: 11313781
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Preclinical animal models for hemophilia gene therapy: predictive value and limitations.
    Rawle FE, Lillicrap D.
    Semin Thromb Hemost; 2004 Apr; 30(2):205-13. PubMed ID: 15118932
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 34.